A Clinician’s Guide for Trending Cardiovascular Nutritional Controversies in 2026 (JACC: Advances March 2026)-Article: A Clinician’s Guide for Trending Cardiovascular Nutritional Controversies in 2026

Article: A Clinician’s Guide for Trending Cardiovascular Nutritional Controversies in 2026

Pdf Summary

This 2026 state-of-the-art review in <em>JACC: Advances</em> summarizes evidence behind several high-profile nutrition debates relevant to cardiovascular disease (CVD) prevention. While core principles of heart-healthy eating remain consistent, the authors evaluate “trending” controversial items—beef tallow, ultraprocessed foods (UPFs), full-fat dairy, seed oils, medium-chain triglyceride (MCT) oils, seafood, and alternative sweeteners—and group them into: (1) evidence of harm (limit/avoid), (2) insufficient evidence for harm or benefit, and (3) evidence of benefit.

<strong>Evidence of harm</strong> includes <strong>beef tallow</strong>, <strong>UPFs</strong>, and <strong>artificial sweeteners/sugar alcohols</strong>. Beef tallow is high in saturated fat and is consistently linked to increased LDL cholesterol versus unsaturated oils; additional concerns include endothelial dysfunction (especially with high-heat/reused fats), impaired insulin sensitivity, fatty liver, and reduced gut microbial diversity. UPFs—now providing over half of U.S. calories—are associated in large observational datasets with obesity, diabetes, hypertension, CVD, cancers, and premature mortality; controlled feeding trials show UPFs increase calorie intake and weight gain, likely due to hyperpalatability, disrupted food structure (“food matrix”), additives, and packaging contaminants. Artificial sweeteners may help modestly with weight when replacing sugar-sweetened beverages, but cohort studies associate higher intake with increased cardiovascular events and mortality; mechanistic data raise concerns about insulin resistance, endothelial effects, microbiome disruption, and inflammation. Sugar alcohols (notably erythritol/xylitol) are linked to thrombosis-related mechanisms and higher cardiovascular event risk in recent studies.

<strong>Insufficient/uncertain evidence</strong> applies to <strong>full-fat dairy</strong>, <strong>MCT oils</strong>, <strong>monk fruit</strong>, and <strong>stevia</strong>. Full-fat dairy shows largely neutral associations with CVD in cohorts, but can raise LDL compared with low-fat dairy; overall evidence does not clearly favor either, though dairy appears preferable to red meat and less optimal than plant proteins. MCTs have niche medical uses (eg, familial chylomicronemia, malabsorption, ketogenic therapy for epilepsy) and may modestly affect weight short-term, but lack long-term CVD outcome trials.

<strong>Evidence of benefit</strong> supports <strong>seed oils</strong> and <strong>seafood</strong>. Seed oils (rich in unsaturated fats) improve lipids and cardiometabolic risk factors without human evidence of proinflammatory effects; confusion often stems from trans-fat history and omega-6:omega-3 ratio misinterpretation. Seafood—especially fatty fish—reduces CVD risk, with practical guidance to minimize contaminant exposure by avoiding high-mercury species and following advisories.

Keywords

cardiovascular disease prevention

heart-healthy diet

beef tallow

ultraprocessed foods (UPFs)

artificial sweeteners

sugar alcohols (erythritol, xylitol)

full-fat dairy

medium-chain triglyceride (MCT) oil

seed oils (unsaturated fats)

seafood and fatty fish